An ALK-1 immunostain should be performed on lymphomas with large cell morphology characterized by immunoblastic, plasmacytoid, or plasmablastic features in order to assess the likelihood of ALK-positive large B-cell lymphoma [63]. This evidence concerns the gene ALK and lymphoma.